269 related articles for article (PubMed ID: 21700552)
21. Preservation of fertility in females with haematological malignancy.
Donnez J; Dolmans MM
Br J Haematol; 2011 Jul; 154(2):175-84. PubMed ID: 21564077
[TBL] [Abstract][Full Text] [Related]
22. Prevention of chemotherapy-induced ovarian damage: possible roles for hormonal and non-hormonal attenuating agents.
Roness H; Kalich-Philosoph L; Meirow D
Hum Reprod Update; 2014; 20(5):759-74. PubMed ID: 24833728
[TBL] [Abstract][Full Text] [Related]
23. Fertility preservation options for women with malignancies.
Marhhom E; Cohen I
Obstet Gynecol Surv; 2007 Jan; 62(1):58-72. PubMed ID: 17176489
[TBL] [Abstract][Full Text] [Related]
24. Fertility sparing in cancer patients.
Bouchlariotou S; Tsikouras P; Benjamin R; Neulen J
Minim Invasive Ther Allied Technol; 2012 Jul; 21(4):282-92. PubMed ID: 21919808
[TBL] [Abstract][Full Text] [Related]
25. Impact of breast cancer chemotherapy on ovarian reserve: a prospective observational analysis by menstrual history and ovarian reserve markers.
Reh A; Oktem O; Oktay K
Fertil Steril; 2008 Nov; 90(5):1635-9. PubMed ID: 18166178
[TBL] [Abstract][Full Text] [Related]
26. Timing of fertility preservation procedures in a cohort of female patients with cancer.
Jenninga E; Louwe LA; Peters AA; Nortier JW; Hilders CG
Eur J Obstet Gynecol Reprod Biol; 2012 Feb; 160(2):170-3. PubMed ID: 22137982
[TBL] [Abstract][Full Text] [Related]
27. Fertility options in young breast cancer survivors: a review of the literature.
Dow KH; Kuhn D
Oncol Nurs Forum; 2004 May; 31(3):E46-53. PubMed ID: 15152274
[TBL] [Abstract][Full Text] [Related]
28. Influence of adjuvant chemotherapy on anti-Müllerian hormone in women below 35 years treated for early breast cancer.
Perdrix A; Saint-Ghislain M; Degremont M; David M; Khaznadar Z; Loeb A; Leheurteur M; Di Fiore F; Clatot F
Reprod Biomed Online; 2017 Oct; 35(4):468-474. PubMed ID: 28652099
[TBL] [Abstract][Full Text] [Related]
29. Adjuvant therapy with GnRH agonists/tamoxifen in breast cancer should be a good council for patients with hormone receptor-positive tumours and wish to preserve fertility.
Franco JG; Oliveira JB; Petersen CG; Mauri AL; Baruffi R; Cavagna M
Med Hypotheses; 2012 Apr; 78(4):442-5. PubMed ID: 22284634
[TBL] [Abstract][Full Text] [Related]
30. Fertility after breast cancer.
Christinat A; Pagani O
Maturitas; 2012 Nov; 73(3):191-6. PubMed ID: 23020991
[TBL] [Abstract][Full Text] [Related]
31. Cancer and fertility preservation: fertility preservation in breast cancer patients.
Maltaris T; Weigel M; Mueller A; Schmidt M; Seufert R; Fischl F; Koelbl H; Dittrich R
Breast Cancer Res; 2008; 10(2):206. PubMed ID: 18492214
[TBL] [Abstract][Full Text] [Related]
32. Fertility preservation and reproductive health in the pediatric, adolescent, and young adult female cancer patient.
Trudgen K; Ayensu-Coker L
Curr Opin Obstet Gynecol; 2014 Oct; 26(5):372-80. PubMed ID: 25160517
[TBL] [Abstract][Full Text] [Related]
33. Breast cancer in young women: effect of chemotherapy on ovarian function, fertility, and birth defects.
Reichman BS; Green KB
J Natl Cancer Inst Monogr; 1994; (16):125-9. PubMed ID: 7999454
[TBL] [Abstract][Full Text] [Related]
34. Update on fertility preservation in young women undergoing breast cancer and ovarian cancer therapy.
Lambertini M; Ginsburg ES; Partridge AH
Curr Opin Obstet Gynecol; 2015 Feb; 27(1):98-107. PubMed ID: 25490381
[TBL] [Abstract][Full Text] [Related]
35. Review. Fertility preservation for young female cancer patients.
Maltaris T; Beckmann MW; Dittrich R
In Vivo; 2009; 23(1):123-30. PubMed ID: 19368136
[TBL] [Abstract][Full Text] [Related]
36. The influence of endocrine effects of adjuvant therapy on quality of life outcomes in younger breast cancer survivors.
Knobf MT
Oncologist; 2006 Feb; 11(2):96-110. PubMed ID: 16476831
[TBL] [Abstract][Full Text] [Related]
37. Oncofertility: an emerging discipline in obstetrics and gynecology.
Lange S; Tait D; Matthews M
Obstet Gynecol Surv; 2013 Aug; 68(8):582-93. PubMed ID: 23921672
[TBL] [Abstract][Full Text] [Related]
38. Amenorrhea, fertility preservation, and counseling among young women treated with anthracyclines and taxanes for early-stage breast cancer, a retrospective study.
Abdel-Razeq HN; Mansour RA; Ammar KS; Abdel-Razeq RH; Zureigat HY; Yousef LM; Shahin OA
Medicine (Baltimore); 2020 Mar; 99(11):e19566. PubMed ID: 32176115
[TBL] [Abstract][Full Text] [Related]
39. Ovarian function, reproduction and strategies for fertility preservation after breast cancer.
Tomao F; Spinelli GP; Panici PB; Frati L; Tomao S
Crit Rev Oncol Hematol; 2010 Oct; 76(1):1-12. PubMed ID: 20185328
[TBL] [Abstract][Full Text] [Related]
40. Issues with Fertility in Young Women with Breast Cancer.
Christian N; Gemignani ML
Curr Oncol Rep; 2019 May; 21(7):58. PubMed ID: 31098718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
